Manning Meredith (CIK 1752631) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-18). Recent activity: Sell SLNO (64,507 shares), Sell SLNO (4,864 shares), Sell SLNO (2,100 shares), Sell SLNO (558 shares), Buy SLNO (28,600 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-18 | SOLENO THERAPEUTICS INC (SLNO) | Chief Commercial Officer | Sell | 64,507 | $0 |
| 2026-03-31 | SOLENO THERAPEUTICS INC (SLNO) | Chief Commercial Officer | Sell | 4,864 | $146,115 |
| 2026-03-31 | SOLENO THERAPEUTICS INC (SLNO) | Chief Commercial Officer | Sell | 2,100 | $65,184 |
| 2026-03-31 | SOLENO THERAPEUTICS INC (SLNO) | Chief Commercial Officer | Sell | 558 | $17,700 |
| 2026-01-23 | SOLENO THERAPEUTICS INC (SLNO) | Chief Commercial Officer | Buy | 28,600 | $0 |
| 2025-12-17 | SOLENO THERAPEUTICS INC (SLNO) | Chief Commercial Officer | Sell | 1,922 | $96,004 |
来源：SEC Form 4 申报文件 · 截至 2026-05-18